HPQ (HPQ)

$18.2B
Market Cap
7.5
P/E Ratio
1.18
Beta
6.17%
Dividend Yield
Piotroski 5/9Altman Z 1.6 DistressBeneish M -2.55 CleanROIC−WACC +10.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.6.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for HPQ demonstrates a robust spread of 10.9 percentage points, with an ROIC of 20.3% significantly outpacing the 9.4% cost of equity, suggesting strong underlying operational returns relative to financing costs. However, the DuPont decomposition reveals a structural anomaly where high asset turnover (1.32x) and modest net margins (4.6%) are being amplified by extreme negative leverage (-120.72x), resulting in an anomalous ROE of -730.9%. This distortion likely stems from aggressive debt restructuring or significant equity dilution rather than operational deterioration, a nuance supported by the benign Beneish M-Score of -2.55 which indicates low earnings manipulation risk, alongside a moderate Piotroski F-Score of 5/9 reflecting mixed financial strength trends.

Valuation metrics present a compelling divergence between current pricing and intrinsic value estimates derived from discounted cash flow modeling. The stock trades at a compressed P/E multiple of 7.5x, which appears materially below the DCF-derived fair value target of $29 per share, implying that the market may be discounting future growth potential or overestimating terminal risk premiums. While revenue expansion remains modest at 3.2% year-over-year, the significant gap between current prices and calculated fair value suggests the equity is priced for stagnation despite the company's ability to generate returns well above its weighted average cost of capital.

Risk assessment highlights a notable divergence in insider behavior versus fundamental metrics. Over the preceding ninety-day window, insiders have executed net selling totaling $834,327, creating a cautionary signal that contrasts with the attractive valuation spread and positive ROIC-WACC differential. While the low Altman Z-Score of 1.6 warrants monitoring for potential liquidity constraints or solvency stress given the negative equity multiplier, the combination of deep value pricing and strong capital returns creates an asymmetric setup where downside protection may be limited by insider sentiment while upside remains tethered to management's ability to normalize leverage ratios without further dilution.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →7.4%9.4%11.4%
2%$36$25$19
3%$43$29$21
4%$55$33$23

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=9.4%, terminal growth 3%. Fair value $29 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.6
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.55
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

20.6%
Gross Margin
4.6%
Net Margin
20.3%
ROIC
9.4%
WACC
ROIC − WACC Spread: +10.9%— Positive value creation spread.
+3.2%
Revenue Growth (YoY)
-8.9%
Earnings Growth (YoY)
2.8B
Free Cash Flow
39%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

4.6%
Net Profit Margin
NI ÷ Revenue
×
1.32x
Asset Turnover
Revenue ÷ Assets
×
-120.72x
Equity Multiplier
Assets ÷ Equity
=
-730.9%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

-121.72x
Debt / Equity
0.77x
Current Ratio
5.8x
Interest Coverage
1.2x
Net Debt / EBITDA
12.00%
FCF Yield
4.1B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-834,327
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-03-25BERGH CHARLES VGrant$555,829
2026-03-11CITRINO MARY ANNESold 1/8 qtrsGrant$833,743
2026-03-11CITRINO MARY ANNESold 1/8 qtrsSale$834,327
2026-02-03PATEL KETAN MAGANLALSold 1/8 qtrsOther1,119 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $0.80
Act: $0.71
-11.6%
Q3
✗ Miss
Est: $0.75
Act: $0.75
0.0%
Q2
✓ Beat
Est: $0.92
Act: $0.93
+0.8%
Q1
✓ Beat
Est: $0.77
Act: $0.81
+5.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

6.7
Forward P/E
PEG Ratio
-23.74
Price/Book
19M
Avg Volume
$29.55
52W High
$17.56
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$3.1B
Tracked Passive Exposure
8
ETFs Holding HPQ
0.05%
Avg Weight in ETFs
$6.4T
Total ETF AUM

When investors buy or sell ETFs like SPYD or ONEY, the fund manager is mechanically forced to buy or sell HPQ shares regardless of HPQ's individual fundamentals. We estimate $3.1B of passive capital is structurally linked to HPQ through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in HPQ to visualize passive redemption contagion across ETFs and collateral stocks.

HPQ Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
HPQEpicenterVTIETFVOOETFIVVETFEOGLow RiskMOLow RiskUPSMed RiskTGTLow RiskSTXLow Risk
HPQ Price Drop (%)0

If HPQ (HPQ) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies EOG RESOURCES INC (EOG) as the most exposed collateral stock, sharing 3 ETFs with HPQ. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 32 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

HPQ Ownership Dynamics

Ticker
HPQ

Float lock-up computed from 33 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

HPQ Capital Efficiency

How efficiently does HPQ convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$2.8B
EBITDA
$4.1B
FCF Conversion
68%
Reinvestment Rate
32%
68% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
20.3%
ROIC − WACC Spread
10.9%

HPQ converts 68% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 10.9% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1114,948$22.68$339,020.64
2026-05-081,025,400$20.99$21.5M
2026-05-07226,623$21.41$4.9M
2026-05-069,281$21.15$196,293.15
2026-05-0546,828$20.80$974,022.4
2026-05-0450,092$20.83$1.0M
2026-05-01137,651$20.86$2.9M
2026-04-291,536$19.73$30,305.28
2026-04-202,305$19.88$45,823.4
2026-04-17599,950$19.72$11.8M
2026-04-16130$19.23$2,499.9
2026-04-15621$18.99$11,792.79
2026-04-074,020$18.94$76,138.8
2026-04-0620,828$19.51$406,354.28
2026-04-01101,669$19.21$2.0M
2026-03-319,333$19.05$177,793.65
2026-03-3012,235$19.44$237,848.4
2026-03-2756,068$19.32$1.1M
2026-03-26112$19.46$2,179.52
2026-03-2593$18.89$1,756.77
2026-03-24404$18.53$7,486.12
2026-03-231,804,780$18.27$33.0M
2026-03-1313,832$18.95$262,116.4
2026-03-104,277$18.93$80,963.61
2026-03-095,453$19.46$106,115.38
2026-03-021,100$18.99$20,889
2026-02-17217,422$19.26$4.2M
2026-02-1164$19.81$1,267.84
2026-02-096,018$19.65$118,253.7
2026-02-05104$19.82$2,061.28

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare HPQ to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.